491 results on '"Tsuzuki, Shinya"'
Search Results
2. Evaluation of antimicrobial selective pressure using the multicenter semiautomatic surveillance system Japan surveillance for infection prevention and healthcare epidemiology
3. Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study
4. Disease burden of main bacterial infections in Japan, 2015–2020: A population-level study
5. Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan
6. Trends in teicoplanin loading dose implementation from 2010 to 2019 and evaluation of safety and efficacy factors: a retrospective cohort study based on a Japanese administrative claims database
7. Effects of population age structure on parenteral antimicrobial use estimations
8. Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan
9. Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registry data in Japan
10. Comparison of clinical characteristics and severity of COVID-19 with or without viral co-infection in hospitalized children
11. Differences in COVID-19 treatment across Japan: Analysis of the COVID-19 Registry Japan (COVIREGI-JP)
12. Does the experience of the first assistant affect organ injuries in laparoscopic hysterectomy for benign diseases?
13. Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population
14. The estimated disease burden of COVID-19 in Japan from 2020 to 2021
15. Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma
16. Regional trends in the use of steroids and favipiravir for COVID-19 treatment
17. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
18. Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan
19. Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
20. Factors associated with development and persistence of post-COVID conditions: A cross-sectional study
21. Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a Role
22. Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study
23. Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan
24. Evaluating the cost-effectiveness of a pre-exposure prophylaxis program for HIV prevention for men who have sex with men in Japan
25. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
26. Impact of regional heterogeneity on the severity of COVID-19
27. Methodological Issues in a Retrospective Study on Short-course Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections in China
28. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan
29. Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: A population-level study, Japan, 2015–2018
30. Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study
31. Determinants of clinic doctors’ attitudes concerning antimicrobial prescription for patients with common colds or bronchitis: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases
32. Effects of a nudge-based antimicrobial stewardship program in a pediatric primary emergency medical center
33. The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan
34. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan
35. Impact of regional heterogeneity on the severity of COVID-19
36. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
37. Analysis of Differences in Characteristics of High-Risk Endemic Areas for Contracting Japanese Spotted Fever, Tsutsugamushi Disease, and Severe Fever With Thrombocytopenia Syndrome
38. Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan
39. Difference in clinical courses and causes of COVID-19-related deaths in hospitalized patients infected with omicron and delta variants: A retrospective study in Japan
40. 2259. Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic
41. 201. Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-Hemolytic Streptococci Species: A Single-Center Retrospective Study
42. Cumulative antibiogram preparation among hospitals participating in the Japan Surveillance for Infection Prevention and Healthcare Epidemiology
43. Large-scale Resurgence of Herpangina in Japan, Following the Easing of Coronavirus Disease 2019 Measures
44. Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study
45. Association between post-COVID-19 conditions and male semen quality in Japan: A descriptive investigation
46. Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
47. Efficacy and Viral Dynamics of Tecovirimat in Patients with MPOX: A Multicenter Open-Label, Double-Arm Trial in Japan
48. Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox
49. Cumulative antibiogram preparation among hospitals participating in the Japan Surveillance for Infection Prevention and Healthcare Epidemiology
50. Simulation studies to assess the long-term effects of Japan’s change from trivalent to quadrivalent influenza vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.